16 publications
Name | Date | Type | Actions |
---|---|---|---|
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
Public releases | ||
2023 Half-Year Results Contents |
Half Year Report | ||
2022 ANNUAL RESULTS Annual sales: €540m (up 3.6% as reported) |
Public releases | ||
ANNUAL RESULTS 2022 (slideshow) 01.2022 Highlights |
Annual Report | ||
H1 2021 results H1 2021 results |
Half Year Report | ||
2021 first half results 2021 Half year results |
Public releases | ||
2020 annual results 2020 sales: €427.5m (up 8.0% as reported)
EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%)
Net income - Group share: €19.2m (4.5% of sales)
Cash flow: €92.2m
|
Public releases | ||
Q1 2021 sales Q1 2021 sales : €128M (up 28% at constant exchange rates, up 24% as reported)
Q1 2021 essential sales : €72.6M (up 38% at constant exchange rates, up 36% as reported)
|
Public releases | ||
Availability of the 2020 universal registration document Vetoquinol informs that it has filed its 2020 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 28th, 2021. |
Public releases | ||
2021 Half year Financial Report (french) Half year Financial Report (french version) |
Half Year Report |